APA (7th ed.) Citation

EA, L., NV, K., SG, V., EA, V., D, J., IM, S., . . . MV, B. (2025). Development of an AAV-RNAi strategy to silence the dominant variant GNAO1 c.607G>A linked to encephalopathy. Gene therapy, 32(4), 430. https://doi.org/10.1038/s41434-025-00532-x

Chicago Style (17th ed.) Citation

EA, Lunev, et al. "Development of an AAV-RNAi Strategy to Silence the Dominant Variant GNAO1 C.607G>A Linked to Encephalopathy." Gene Therapy 32, no. 4 (2025): 430. https://doi.org/10.1038/s41434-025-00532-x.

MLA (9th ed.) Citation

EA, Lunev, et al. "Development of an AAV-RNAi Strategy to Silence the Dominant Variant GNAO1 C.607G>A Linked to Encephalopathy." Gene Therapy, vol. 32, no. 4, 2025, p. 430, https://doi.org/10.1038/s41434-025-00532-x.